Mount Sinai Launches Large-Scale Genetic Sequencing Project (“Million Health Discoveries”) with Regeneron Genetics Center; Project Aims to Enroll One Million Racially and Ethnically Diverse Patients, Advance Precision Medicine Research, and Improve Patient Care

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai in New York have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron. This was announced in an August 12,2022 Mount Sinai news release. The Program aims to enroll one million Mount Sinai patients over a five-year period, making it one of the most ambitious projects of its kind and the largest Regeneron-supported sequencing effort to date. Its goal is to provide researchers with a unique data set that will help them assess the true potential of genetics-based, precision medicine approaches to guide everyday patient care, as well as to generate new insights to guide the discovery and development of potential new therapies.

Login Or Register To Read Full Story